Literature DB >> 11788417

Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.

Patrice Colin1, Bijan Ghaleh, Luc Hittinger, Xavier Monnet, Michel Slama, Jean-François Giudicelli, Alain Berdeaux.   

Abstract

Left ventricular (LV) relaxation is crucial for LV function, especially during exercise. We compared the effects of increasing doses of ivabradine, a selective inward hyperpolarization-activated current inhibitor, and atenolol on the rate and extent of LV relaxation (best fit method: time constant tau(BF), pressure asymptote P(BF)) at rest and during exercise. Eight dogs were chronically instrumented to measure LV pressure and LV wall stresses. During exercise under saline, heart rate increased from 108 +/- 5 to 220 +/- 6 beats/min and tau(BF) was significantly reduced from 22 +/- 1 to 14 +/- 2 ms. At rest, atenolol but not ivabradine increased tau(BF). For similar heart rate reductions during exercise, atenolol impeded the shortening of tau(BF) (23 +/- 2 ms) whereas ivabradine had no effect (15 +/- 2 ms). The extent of the relaxation process (P(BF)) at peak exercise was increased by ivabradine, and to a greater extent by atenolol, compared with saline. Thus, for a similar reduction in heart rate at rest and during exercise, ivabradine, in contrast with atenolol, does not exert any negative lusitropic effect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788417     DOI: 10.1152/ajpheart.00547.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  29 in total

Review 1.  Heart rate: a forgotten link in coronary artery disease?

Authors:  Kim M Fox; Roberto Ferrari
Journal:  Nat Rev Cardiol       Date:  2011-04-26       Impact factor: 32.419

2.  Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.

Authors:  Robinson Joannides; Nicholas Moore; Michaela Iacob; Patricia Compagnon; Guy Lerebours; Jean-François Menard; Christian Thuillez
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

3.  Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.

Authors:  L Lucats; B Ghaleh; P Colin; X Monnet; A Bizé; A Berdeaux
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

4.  [New therapy concepts for heart failure with preserved ejection fraction].

Authors:  C Tschöpe; B Pieske
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

Review 5.  Heart rate reduction in heart failure: ivabradine or beta blockers?

Authors:  Maya Guglin
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

6.  Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.

Authors:  Nicolas Couvreur; Renaud Tissier; Sandrine Pons; Valérie Chetboul; Vassiliky Gouni; Patrick Bruneval; Chantal Mandet; Jean-Louis Pouchelon; Alain Berdeaux; Bijan Ghaleh
Journal:  Eur Heart J       Date:  2009-12-21       Impact factor: 29.983

Review 7.  Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept.

Authors:  Markus Meyer; Mehdi Rambod; Martin LeWinter
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 8.  Preclinical results with I(f) current inhibition by ivabradine.

Authors:  Alain Berdeaux
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Impaired left ventricular function in the presence of preserved ejection in chronic hypertensive conscious pigs.

Authors:  Mario Rienzo; Alain Bizé; Dionyssis Pongas; Stéphanie Michineau; Jonathan Melka; Hon Lai Chan; Lucien Sambin; Jin Bo Su; Jean-Luc Dubois-Randé; Luc Hittinger; Alain Berdeaux; Bijan Ghaleh
Journal:  Basic Res Cardiol       Date:  2012-09-09       Impact factor: 17.165

10.  Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.

Authors:  Jan-Christian Reil; Mathias Hohl; Gert-Hinrich Reil; Henk L Granzier; Mario T Kratz; Andrey Kazakov; Peter Fries; Andreas Müller; Matthias Lenski; Florian Custodis; Stefan Gräber; Gerd Fröhlig; Paul Steendijk; Hans-Ruprecht Neuberger; Michael Böhm
Journal:  Eur Heart J       Date:  2012-07-24       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.